CVRx, Inc. (NASDAQ: CVRX) ('CVRx”), a commercial-stage medical device company focused on developing, manufacturing and ...
"Publication of the new AMA CPT code represents a significant milestone for Sensydia, and will help foster the adoption of our nninvasive, in-clinic hemodynamic assessment tool by establishing a ...
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), a leader in artificial intelligence-driven precision cardiovascular medicine tests, today announced the American Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback